Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study ; volume:18 ; number:1 ; day:8 ; month:1 ; year:2018 ; pages:1-7 ; date:12.2018
BMC cancer ; 18, Heft 1 (8.1.2018), 1-7, 12.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Dall, Peter
- Beteiligte Personen und Organisationen
-
Koch, Thorsten
Göhler, Thomas
Selbach, Johannes
Ammon, Andreas
Eggert, Jochen
Gazawi, Nidal
Rezek, Daniela
Wischnik, Arthur
Hielscher, Carsten
Schleif, Nicolas
Cirrincione, Ursula
Hinke, Axel
Feisel-Schwickardi, Gabriele
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3857-5
- URN
-
urn:nbn:de:1111-20180226592
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dall, Peter
- Koch, Thorsten
- Göhler, Thomas
- Selbach, Johannes
- Ammon, Andreas
- Eggert, Jochen
- Gazawi, Nidal
- Rezek, Daniela
- Wischnik, Arthur
- Hielscher, Carsten
- Schleif, Nicolas
- Cirrincione, Ursula
- Hinke, Axel
- Feisel-Schwickardi, Gabriele
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Adjuvant Trastuzumab: Do we finally know how long is not too long?
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Adjuvant Trastuzumab: Do we finally know how long is not too long?
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report
Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Adjuvant Trastuzumab: Do we finally know how long is not too long?
Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial
Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report